Experienced in Liver Failure

Dr. Jonathan D. Powell

Oncology
600 N Wolfe St, 
Baltimore, MD 
Experienced in Liver Failure
600 N Wolfe St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jonathan Powell is an Oncologist in Baltimore, Maryland. Dr. Powell is rated as an Experienced provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Reticulohistiocytoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma, and Rosai-Dorfman Disease.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Internal Medicine in MD
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

600 N Wolfe St, Baltimore, MD 21287

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess Its Efficacy, Safety, Impact on Quality of Life, and Long-term Outcome in Pediatric Patients With Primary Hemophagocytic Lymphohistiocytosis
An Open-label, Single Arm, Multicenter Study to Broaden Access to Emapalumab, an Anti-Interferon Gamma (Anti-IFNγ) Monoclonal Antibody, and to Assess Its Efficacy, Safety, Impact on Quality of Life, and Long-term Outcome in Pediatric Patients With Primary Hemophagocytic Lymphohistiocytosis
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: Emapalumab
Study Phase: Phase 3
A Phase 2/3 Open-label Single Arm Multicentre Study to Assess Safety Tolerability Pharmacokinetics and Efficacy of i.v. Administrations of NI-0501 an Anti-IFNγ mAb in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis
A Phase 2/3 Open-label Single Arm Multicentre Study to Assess Safety Tolerability Pharmacokinetics and Efficacy of i.v. Administrations of NI-0501 an Anti-IFNγ mAb in Paediatric Patients With Primary Haemophagocytic Lymphohistiocytosis
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: January 13, 2023
Intervention Type: Drug
Study Drugs: Vincristine, Irinotecan, Temozolomide, Metformin
Study Phase: Phase 1
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Pediatric Blood & Marrow Transplant Consortium (PBMTC) Phase II Myeloablative Haploidentical BMT With Post-transplantation Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Pediatric Blood & Marrow Transplant Consortium (PBMTC) Phase II Myeloablative Haploidentical BMT With Post-transplantation Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Enrollment Status: Completed
Publish Date: November 26, 2021
Intervention Type: Radiation, Other, Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

124 Total Publications

Systematic metabolite screening identifies functional regulators of the adenosine A2A receptor.
Systematic metabolite screening identifies functional regulators of the adenosine A2A receptor.
Journal: Communications chemistry
Published: June 18, 2025
Similar Doctors
Experienced in Liver Failure
Dr. Kathiresan Suppiah
Hematology Oncology | Hematology | Oncology
Experienced in Liver Failure
Dr. Kathiresan Suppiah
Hematology Oncology | Hematology | Oncology

Christiana Care Health Services Inc

1011 W Baltimore Pike, 307 Cchs Oncology West Gro, 
West Grove, PA 
 (52.1 miles away)
610-869-1455
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kathiresan Suppiah is a Hematologist Oncology specialist and a Hematologist in West Grove, Pennsylvania. Dr. Suppiah is rated as an Advanced provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, Bone Marrow Aspiration, and Gastrostomy. Dr. Suppiah is currently accepting new patients.

Experienced in Liver Failure
Dr. Khurram Anwar
Oncology
Experienced in Liver Failure
Dr. Khurram Anwar
Oncology

Inova Health Care Services

44045 Rivderside Pkwy, 
Leesburg, VA 
 (49.9 miles away)
703-771-2960
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Khurram Anwar is an Oncologist in Leesburg, Virginia. Dr. Anwar has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Liver Failure. His top areas of expertise are Angioimmunoblastic T-cell Lymphoma, Gallbladder Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Pacemaker Implantation, and Hip Replacement. Dr. Anwar is currently accepting new patients.

Experienced in Liver Failure
Dr. Khadega A. Abuelgasim-Ahmed
Hematology | Oncology
Experienced in Liver Failure
Dr. Khadega A. Abuelgasim-Ahmed
Hematology | Oncology

Christiana Care Health Services Inc

4701 Ogletown Stanton Rd, Suite 2100, 
Newark, DE 
 (55.9 miles away)
302-623-4960
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Khadega Abuelgasim-Ahmed is a Hematologist and an Oncologist in Newark, Delaware. Dr. Abuelgasim-Ahmed is rated as an Advanced provider by MediFind in the treatment of Liver Failure. Her top areas of expertise are Pulmonary Embolism, Saddle Pulmonary Embolism, Thrombocytopenia, and Febrile Neutropenia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Powell's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile